Variation in gene expression patterns in follicular lymphoma and the response to rituximab

AUTOR(ES)

Bohen, Sean P.

FONTE

The National Academy of Sciences

RESUMO

Analysis of the patterns of gene expression in follicular lymphomas from 24 patients suggested that two groups of tumors might be distinguished. All patients, whose biopsies were obtained before any treatment, were treated with rituximab, a monoclonal antibody directed against the B cell antigen, CD20. Gene expression patterns in the tumors that subsequently failed to respond to rituximab appeared more similar to those of normal lymphoid tissues than to gene expression patterns of tumors from rituximab responders. These findings suggest the possibility that the response of follicular lymphoma to rituximab treatment may be predicted from the gene expression pattern of tumors.

Documentos Relacionados

• Development of a drug–disease simulation model for rituximab in follicular non-Hodgkin's lymphoma
• Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes
• Individuality and variation in gene expression patterns in human blood
• Variation in Gene Expression Patterns in Human Gastric Cancers
• Gene Expression Profile of Campylobacter jejuni in Response to Growth Temperature Variation